Peroxynitrite inhibits myofibrillar protein function in an in vitro assay of motility

Free Radical Biology and Medicine

Volumn 44, Issue 1, 2008, Pages 14-23

  Snook, Jeremy H ^a   Li, Jiahui ^a   Helmke, Brian P ^a   Guilford, William H ^a  

^a University of Virginia   (United States)

Author keywords

Actin; Cardiac muscle; Free radicals; Myosin; Oxidative stress

Indexed keywords

ACTIN; CARDIAC MYOSIN; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN ALPHA; PEROXYNITRITE;

ACTIN FILAMENT; ANIMAL TISSUE; ARTICLE; CELL MOTILITY; DRUG EFFECT; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MYOFILAMENT; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; RAT; THIN FILAMENT;

ACTINS; ALGORITHMS; ANIMALS; CALCIUM; CARDIAC MYOSINS; MODELS, MOLECULAR; MOLECULAR MOTOR PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOFIBRILS; OXIDATIVE STRESS; PEROXYNITROUS ACID; RATS; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 36248973660     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.09.004     Document Type: Article

References (61)

1. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90 (1993) 7915-7922
2. Andrade F.H., Reid M.B., and Westerblad H. Contractile response of skeletal muscle to low peroxide concentrations: myofibrillar calcium sensitivity as a likely target for redox-modulation. FASEB J. 15 (2001) 309-311
3. Arstall M.A., Sawyer D.B., Fukazawa R., and Kelly R.A. Cytokine-mediated apoptosis in cardiac myocytes-the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ. Res. 85 (1999) 829-840
4. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., and White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 375 (1994) 81-88
5. Borbely A., Toth A., Edes I., Virag L., Papp J.G., Varro A., Paulus W.J., van d V., Stienen G.J., and Papp Z. Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. Cardiovasc. Res. 67 (2005) 225-233
6. Brunelli L., Crow J.P., and Beckman J.S. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316 (1995) 327-334
7. Crocker J.C., and Grier D.G. Methods of digital video microscopy for colloidal studies. J. Colloid Interface Sci. 179 (1996) 298-310
8. Crow J.P., and Ischiropoulos H. Detection and quantitation of nitrotyrosine residues in proteins: in vivo marker of peroxynitrite. Methods Enzymol. 269 (1996) 185-194
9. Cuda G., Fananapazir L., Epstein N.D., and Sellers J.R. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J. Muscle Res. Cell Motil. 18 (1997) 275-283
10. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Di Simplicio P., Colombo R., and Milzani A. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic. Biol. Med. 32 (2002) 927-937
11. Dalle-Donne I., Rossi R., Giustarini D., Gagliano N., Lusini L., Milzani A., Di Simplicio P., and Colombo R. Actin carbonylation: from a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic. Biol. Med. 31 (2001) 1075-1083
12. Dedon P.C., and Tannenbaum S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423 (2004) 12-22
13. Digerness S.B., Harris K.D., Kirklin J.W., Urthaler F., Viera L., Beckman J.S., and Darley-Usmar V. Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic. Biol. Med. 27 (1999) 1386-1392
14. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., and Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 87 (2000) 241-247
15. Guo B., and Guilford W.H. The tail of myosin reduces actin filament velocity in the in vitro motility assay. Cell Motil. Cytoskelet. 59 (2004) 264-272
16. Harris D.E., Work S.S., Wright R.K., Alpert N.R., and Warshaw D.M. Smooth, cardiac and skeletal muscle myosin force and motion generation assessed by cross-bridge mechanical interactions in vitro. J. Muscle Res. Cell Motil. 15 (1994) 11-19
17. Huxley A.F. Muscle structure and theories of contraction. Prog. Biophys. Biophys. Chem. 7 (1957) 255-318
18. Ischiropoulos H., and al Mehdi A.B. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364 (1995) 279-282
19. Ischiropoulos H., and Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J. Clin. Invest. 111 (2003) 163-169
20. Jagtap P., and Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev., Drug Discov. 4 (2005) 421-440
21. Kanski J., Behring A., Pelling J., and Schoneich C. Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H371-H381
22. Korhonen R., Lahti A., Kankaanranta H., and Moilanen E. Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflammation Allergy 4 (2005) 471-479
23. Kron S.J., and Spudich J.A. Fluorescent actin filaments move on myosin fixed to a glass surface. Proc. Natl. Acad. Sci. USA 83 (1986) 6272-6276
24. Landino L.M., Hasan R., McGaw A., Cooley S., Smith A.W., Masselam K., and Kim G. Peroxynitrite oxidation of tubulin sulfhydryls inhibits microtubule polymerization. Arch. Biochem. Biophys. 398 (2002) 213-220
25. Lehman W., Vibert P., Uman P., and Craig R. Steric-blocking by tropomyosin visualized in relaxed vertebrate muscle thin filaments. J. Mol. Biol. 251 (1995) 191-196
26. Levrand S., Vannay-Bouchiche C., Pesse B., Pacher P., Feihl F., Waeber B., and Liaudet L. Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic. Biol. Med. 41 (2006) 886-895
27. Liu P., Hock C.E., Nagele R., and Wong P.Y. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am. J. Physiol. 272 (1997) H2327-H2336
28. Liu P., Xu B., Quilley J., and Wong P.Y. Peroxynitrite attenuates hepatic ischemia-reperfusion injury. Am. J. Physiol.: Cell Physiol. 279 (2000) C1970-C1977
29. Ma X.L., Lopez B.L., Liu G.L., Christopher T.A., and Ischiropoulos H. Peroxynitrite aggravates myocardial reperfusion injury in the isolated perfused rat heart. Cardiovasc. Res. 36 (1997) 195-204
30. Malinski T. Understanding nitric oxide physiology in the heart: a nanomedical approach. Am. J. Cardiol. 96 (2005) 13i-24i
31. Martin A.F., Rabinowitz M., Blough R., Prior G., and Zak R. Measurements of half-life of rat cardiac myosin heavy chain with leucyl-tRNA used as precursor pool. J . Biol. Chem. 252 (1977) 3422-3429
32. McClellan G., Kulikovskaya I., and Winegrad S. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C. Biophys. J. 81 (2001) 1083-1092
33. Mihm M.J., and Bauer J.A. Peroxynitrite-induced inhibition and nitration of cardiac myofibrillar creatine kinase. Biochimie 84 (2002) 1013-1019
34. Mihm M.J., Coyle C.M., Schanbacher B.L., Weinstein D.M., and Bauer J.A. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 49 (2001) 798-807
35. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
36. Mihm M.J., Yu F., Weinstein D.M., Reiser P.J., and Bauer J.A. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br. J. Pharmacol. 135 (2002) 581-588
37. 2+ sensitivity in fatiguing mouse skeletal muscle at 37°C. J. Physiol. 564 (2005) 189-199
38. Oakley C.E., Chamoun J., Brown L.J., and Hambly B.D. Myosin binding protein-C: enigmatic regulator of cardiac contraction. Int. J. Biochem. Cell Biol. 39 (2007) 2161-2166
39. Okamoto T., Akaike T., Nagano T., Miyajima S., Suga M., Ando M., Ichimori K., and Maeda H. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch. Biochem. Biophys. 342 (1997) 261-274
40. Pardee J.D., and Spudich J.A. Purification of muscle actin. Methods Enzymol. 85 Pt B (1982) 164-181
41. Patton C., Thompson S., and Epel D. Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium 35 (2004) 427-431
42. Powell S.R., Gurzenda E.M., and Wahezi S.E. Actin is oxidized during myocardial ischemia. Free Radic. Biol. Med. 30 (2001) 1171-1176
43. Rao A.V., and Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr. Neurosci. 5 (2002) 291-309
44. Rao V.S., La Bonte L.R., Xu Y., Yang Z., French B.A., and Guilford W.H. Alterations to myofibrillar protein function in non-ischemic regions of the heart early after myocardial infarction. Am. J. Physiol. 293 (2007) H654-H659
45. Rasband W.S. NIH Image, ImageJ. (1997), National Institutes of Health, Bethesda, MD
46. Rojas A., Figueroa H., Re L., and Morales M.A. Oxidative stress at the vascular wall: mechanistic and pharmacological aspects. Arch. Med. Res. 37 (2006) 436-448
47. Shaffer J.F., Razumova M.V., Tu A.Y., Regnier M., and Harris S.P. Myosin S2 is not required for effects of myosin binding protein-C on motility. FEBS Lett. 581 (2007) 1501-1504
48. Shishehbor M.H., Aviles R.J., Brennan M.L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney Jr. J.F., Penn M.S., Sprecher D.L., Vita J.A., and Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
49. Shiverick K.T., Thomas L.L., and Alpert N.R. Purification of cardiac myosin: application to hypertrophied myocardium. Biochim. Biophys. Acta 393 (1975) 124-133
50. Sugiura S., Kobayakawa N., Momomura S., Chaen S., Omata M., and Sugi H. Different cardiac myosin isoforms exhibit equal force-generating ability in vitro. Biochim. Biophys. Acta 1273 (1996) 73-76
51. Supinski G., Stofan D., Callahan L.A., Nethery D., Nosek T.M., and DiMarco A. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm. J. Appl. Physiol. 87 (1999) 783-791
52. Tiago T., Simao S., Aureliano M., Martin-Romero F.J., and Gutierrez-Merino C. Inhibition of skeletal muscle S1-myosin ATPase by peroxynitrite. Biochemistry 45 (2006) 3794-3804
53. Tien M., Berlett B.S., Levine R.L., Chock P.B., and Stadtman E.R. Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation. Proc. Natl. Acad. Sci. USA 96 (1999) 7809-7814
54. VanBuren P., Palmiter K.A., and Warshaw D.M. Tropomyosin directly modulates actomyosin mechanical performance at the level of a single actin filament. Proc. Natl. Acad. Sci. USA 96 (1999) 12488-12493
55. Wang P., and Zweier J.L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271 (1996) 29223-29230
56. Warshaw D.M., Desrosiers J.M., Work S.S., and Trybus K.M. Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro. J. Cell. Biol. 111 (1990) 453-463
57. Weinstein D.M., Mihm M.J., and Bauer J.A. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J. Pharmacol. Exp. Ther. 294 (2000) 396-401
58. Yamashita H., Sugiura S., Fujita H., Yasuda S., Nagai R., Saeki Y., Sunagawa K., and Sugi H. Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction. Cardiovasc. Res. 60 (2003) 580-588
59. Yasmin W., Strynadka K.D., and Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res. 33 (1997) 422-432
60. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., and Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc. Res. 36 (1997) 205-215
61. Zweier J.L., Fertmann J., and Wei G. Nitric oxide and peroxynitrite in postischemic myocardium. Antioxid. Redox Signal. 3 (2001) 11-22